Switch to:
AbbVie Inc  (NYSE:ABBV) Piotroski F-Score: 5 (As of Today)

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

AbbVie Inc has an F-score of 5 indicating the company's financial situation is typical for a stable company.

NYSE:ABBV' s Piotroski F-Score Range Over the Past 10 Years
Min: 5   Max: 8
Current: 5

5
8

During the past 8 years, the highest Piotroski F-Score of AbbVie Inc was 8. The lowest was 5. And the median was 6.


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

AbbVie Inc Annual Data

Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Piotroski F-Score Premium Member Only Premium Member Only Premium Member Only 8.00 6.00 5.00 7.00 6.00

AbbVie Inc Quarterly Data

Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17
Piotroski F-Score Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.00 6.00 6.00 6.00 5.00

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.

How is the Piotroski F-Score calculated?

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

This Year (Jun17) TTM:Last Year (Jun16) TTM:
Net Income was 1598 + 1391 + 1711 + 1915 = $6,615 Mil.
Cash Flow from Operations was 1454 + 1541 + 2102 + 2003 = $7,100 Mil.
Revenue was 6432 + 6796 + 6538 + 6944 = $26,710 Mil.
Gross Profit was 4928 + 5241 + 4922 + 5416 = $20,507 Mil.
Average Total Assets from the begining of this year (Jun16)
to the end of this year (Jun17) was
(67211 + 66626 + 66099 + 65664 + 66994) / 5 = $66518.8 Mil.
Total Assets at the begining of this year ({FiscalYear0}) was $67,211 Mil.
Long-Term Debt & Capital Lease Obligation was $33,817 Mil.
Total Current Assets was $16,962 Mil.
Total Current Liabilities was $12,259 Mil.
Total Assets was 1239 + 1517 + 1354 + 1610 = $5,720 Mil.

Revenue was 5944 + 6400 + 5958 + 6452 = $24,754 Mil.
Gross Profit was 4777 + 4925 + 4589 + 5047 = $19,338 Mil.
Average Total Assets from the begining of last year (Jun15)
to the end of last year (Jun16) was
(53855 + 54832 + 53050 + 53720 + 67211) / 5 = $56533.6 Mil.
Total Assets at the begining of last year (Jun15) was $53,855 Mil.
Long-Term Debt & Capital Lease Obligation was $37,328 Mil.
Total Current Assets was $16,791 Mil.
Total Current Liabilities was $9,272 Mil.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

AbbVie Inc's current Net Income (TTM) was {NetIncome0_f}. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

AbbVie Inc's current Cash Flow from Operations (TTM) was 7,100. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets(Jun16)
=6615/67211
=0.09842139

ROA (Last Year)=Net Income/Total Assets(Jun15)
=5720/53855
=0.10621112

AbbVie Inc's return on assets of this year was 0.09842139. AbbVie Inc's return on assets of last year was 0.10621112. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

AbbVie Inc's current Net Income (TTM) was 6,615. AbbVie Inc's current Cash Flow from Operations (TTM) was 7,100. ==> 7,100 > 6,615 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Jun17)=Long-Term Debt & Capital Lease Obligation/Total Assetsfrom Jun16 to Jun17
=33817/66518.8
=0.50838259

Gearing (Last Year: Jun16)=Long-Term Debt & Capital Lease Obligation/Total Assetsfrom Jun15 to Jun16
=37328/56533.6
=0.6602799

AbbVie Inc's gearing of this year was 0.50838259. AbbVie Inc's gearing of last year was 0.6602799. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Jun17)=Total Current Assets/Total Current Liabilities
=16962/12259
=1.38363651

Current Ratio (Last Year: Jun16)=Total Current Assets/Total Current Liabilities
=16791/9272
=1.81093615

AbbVie Inc's current ratio of this year was 1.38363651. AbbVie Inc's current ratio of last year was 1.81093615. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

AbbVie Inc's number of shares in issue this year was 1600. AbbVie Inc's number of shares in issue last year was 1632. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=20507/26710
=0.76776488

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=19338/24754
=0.78120708

AbbVie Inc's gross margin of this year was 0.76776488. AbbVie Inc's gross margin of last year was 0.78120708. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Jun16)
=26710/67211
=0.39740519

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Jun15)
=24754/53855
=0.45964163

AbbVie Inc's asset turnover of this year was 0.39740519. AbbVie Inc's asset turnover of last year was 0.45964163. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+0+1+1+0+1+0+0
=5

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

AbbVie Inc has an F-score of 5 indicating the company's financial situation is typical for a stable company.

Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Related Terms

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK